Rapid Micro Biosystems (RPID) Invested Capital (2020 - 2026)

Rapid Micro Biosystems has disclosed Invested Capital across 7 years of filings, most recently posting $40.4 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $40.4 million, down 38.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.4 million (down 38.32% YoY), and the FY2025 annual result was $53.2 million, down 29.39% from the prior year.
• Invested Capital came in at $40.4 million for Q1 2026 at Rapid Micro Biosystems, down from $53.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $207.1 million in Q1 2022 to a low of $40.4 million in Q1 2026.
• The 5-year median for Invested Capital is $105.9 million (2024), against an average of $113.0 million.
• Across the five-year window, Invested Capital surged 237.09% in 2022 and slumped 42.33% in 2025, its largest moves.
• Rapid Micro Biosystems' Invested Capital stood at $164.2 million in 2022, then dropped by 28.13% to $118.0 million in 2023, then plunged by 36.14% to $75.4 million in 2024, then retreated by 29.39% to $53.2 million in 2025, then dropped by 24.07% to $40.4 million in 2026.
• The last three Invested Capital figures came in at $40.4 million (Q1 2026), $53.2 million (Q4 2025), and $64.3 million (Q3 2025), per Business Quant data.